New CAR T Cells Target Glioblastoma Tumor Microenvironment Protein
Scientists at the University of Geneva (UNIGE) and the Geneva University Hospital (HUG) have engineered a new CAR T cell therapy approach that can destroy glioblastoma cells.
Read more- medicine
